PCR aims to become the gold standard for research that has an impact on advanced prostate cancer. We are committed to being at the forefront of innovation and fostering scientific excellence and, to this end, we will actively seek out exceptional science proposed by outstanding scientists.

To succeed in our mission, we need to further strengthen our credibility and reputation. We aim to be recognised as the leading authority on prostate cancer research among the research community, decision-makers and funders.

Looking out for and nurturing vibrant partnerships is part of the solution to speeding up the development of pioneering treatments for cancer patients in the UK and worldwide. PCR will build bridges between the scientific community, government, pharmaceutical industry and people with prostate cancer.

We have assembled experts to advise us on all aspects of running a successful and robust research charity. We will continue to analyse and assess our skills and experience and fill gaps that may exist in our scientific advisory committee, executive advisory group and board
of trustees.

Our main objectives will be to foster a culture of continuous learning and to build a ‘shared’ sense of purpose and the autonomy to achieve goals. Capturing and preserving knowledge will also be critical to PCR’s organisational effectiveness and long-term success.

We will take a dual approach of bidding for larger grants from government, trusts, companies and high-net-worth individuals, while also strategically investing funds to ensure we build up the type of flexible funding that comes from events and individual giving.